The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ERIC 2024 | Autoimmune cytopenias in CLL and the impact of targeted therapies
Marta Coscia, MD, PhD, University of Insubria and ASST Sette Laghi, Varese, Italy, discusses autoimmune cytopenias as a complication in chronic lymphocytic leukemia (CLL). She explains that the management of these conditions depends on the status of the underlying CLL. This interview took place at the 2024 European Research Initiative on CLL (ERIC) Meeting in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
